NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

The reality is that DCVax Direct and L are just variances in the same modality of treatment and the company has enough evidence to begin broader trials once the reforms are in place.

Can you please present to me the evidence that DCVAX is working for other cancers in other organs than the brain called GBM? I must have missed that. It's would be enough if it's the same blinded blended evidence as we have seen for the GBM trial DCVAX L.

There is no such evidence and there are no active trials for DCVAX as of Feb 9 2022 that's the reality and THUS there is no DCVAX platform (yet).

I suspect no NWBO shareholder will ever see anything remotely what could be called a DCVAX platform. They will sell the company with its patents and an (almost) approved DCVAX L and the new owner can then start other trials with DCVAX technology. That's reality.